A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients (Q44851401)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients |
scientific article published in April 2004 |
Statements
1 reference
A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients (English)
1 reference
Scott McCallister
1 reference
Hernan Valdez
1 reference
Kevin Curry
1 reference
Thomas MacGregor
1 reference
Marie Borin
1 reference
William Freimuth
1 reference
Yenyung Wang
1 reference
Douglas L Mayers
1 reference
1 April 2004
1 reference
1 reference
Identifiers
1 reference